![Naveed Shams](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Naveed Shams
Voorzitter bij InnFocus, Inc.
Profiel
Momenteel bekleedt Naveed K. Shams de functie van Chief Scientific Officer, General Manager-R&D bij Santen Pharmaceutical Co., Ltd., voorzitter bij InnFocus, Inc. (een dochteronderneming van Santen Pharmaceutical Co., Ltd.) en Chief Scientific Officer bij ProQR Therapeutics NV. In zijn vorige carrière was hij CMO, Senior Vice President-Research & Development bij OPKO Health, Inc., Senior Scientist & Glaucoma Group Leader-Discovery bij Storz Ophthalmics, Inc., President, Chief Executive Officer & Director bij Santen, Inc., Senior Medical Director bij Genentech, Inc., Director-Clinical Science bij Novartis Ophthalmics, Inc. en lid-Research Faculty bij Schepens Eye Research Institute. Naveed K. Shams behaalde een doctoraat aan het Dow Medical College en een doctoraat aan de Universiteit van South Carolina.
Actieve functies van Naveed Shams
Bedrijven | Functie | Begin |
---|---|---|
InnFocus, Inc.
![]() InnFocus, Inc. BiotechnologyHealth Technology InnFocus, Inc. operates as an ophthalmology company that provides products for glaucoma surgery. Its product, InnFocus MicroShunt, is a glaucoma drainage implant consisting of a micro-tube twice the size of an eyelash. The company was founded by Leonard Pinchuk and John B. Martin Jr. in 2004 and is headquartered in Miami, FL. | Voorzitter | - |
Eerdere bekende functies van Naveed Shams
Bedrijven | Functie | Einde |
---|---|---|
PROQR THERAPEUTICS N.V. | Hoofd Techniek/Wetenschap/O&O | 01-01-2022 |
OPKO HEALTH, INC. | Hoofd Techniek/Wetenschap/O&O | 10-06-2009 |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Hoofd Techniek/Wetenschap/O&O | 01-11-2007 |
Novartis Ophthalmics, Inc.
![]() Novartis Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Ophthalmics, Inc. was a producer of pharmaceuticals, eye care and generic drugs. The company was headquartered in Duluth, GA. | Hoofd Techniek/Wetenschap/O&O | 01-09-2003 |
Storz Ophthalmics, Inc. | Corporate Officer/Principal | 01-03-1998 |
Opleiding van Naveed Shams
University of South Carolina | Doctorate Degree |
Dow Medical College | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
SANTEN PHARMACEUTICAL CO., LTD. | Health Technology |
OPKO HEALTH, INC. | Health Services |
PROQR THERAPEUTICS N.V. | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
The Schepens Eye Research Institute, Inc.
![]() The Schepens Eye Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The Schepens Eye Research Institute, Inc. operates as an eye research institute. It offers treatment for macular degeneration, diabetic retinopathy, glaucoma, other types of retinal and optic nerve degenerations and damage, dry eye and eye tissue transplants. The company was founded by Charles L. Schepens in 1950 and is headquartered in Boston, MA. | Commercial Services |
Santen, Inc.
![]() Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | Health Technology |
Storz Ophthalmics, Inc. | |
Novartis Ophthalmics, Inc.
![]() Novartis Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Ophthalmics, Inc. was a producer of pharmaceuticals, eye care and generic drugs. The company was headquartered in Duluth, GA. | Health Technology |
InnFocus, Inc.
![]() InnFocus, Inc. BiotechnologyHealth Technology InnFocus, Inc. operates as an ophthalmology company that provides products for glaucoma surgery. Its product, InnFocus MicroShunt, is a glaucoma drainage implant consisting of a micro-tube twice the size of an eyelash. The company was founded by Leonard Pinchuk and John B. Martin Jr. in 2004 and is headquartered in Miami, FL. | Health Technology |